BioNxt Solutions Inc. (BNXT) | WebDisclosure

Basculer en Français

8301	Companies
115081	Keywords
55430	Articles
62520	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

BRIEF

published on 03/13/2024 at 08:10, 8 months 8 days ago

BioNxt rapporte des résultats prometteurs dans l'étude ODF Cladribine pour la SEP

BioNxt Solutions Inc. Sclérose En Plaques Cladribine Étude Pharmacocinétique Technologie D'administration De Médicaments
BRIEF

published on 03/13/2024 at 08:10, 8 months 8 days ago

BioNxt Reports Promising Results in ODF Cladribine Study for MS

BioNxt Solutions Inc. Multiple Sclerosis Cladribine Pharmacokinetic Study Drug Delivery Technology
PRESS RELEASE

published on 03/13/2024 at 08:05, 8 months 8 days ago

BioNxt Reports Successful Results From ODF Cladribine PK Study
BioNxt Solutions Inc. announces successful completion of comparative pharmacokinetic study for its oral dissolvable film Cladribine product for Multiple Sclerosis treatment, demonstrating rapid absorption similar to reference drug

BioNxt Solutions Inc. Multiple Sclerosis Cladribine Pharmacokinetic Study Drug Delivery System
PRESS RELEASE

published on 02/17/2024 at 01:50, 9 months 4 days ago

BioNxt Solutions Finalizes Agreement
BioNxt Solutions Inc. finalizes Settlement Agreement with a creditor to settle $282,415 debt through issuance of common shares and a cash payment. Debt to be settled in three instalments of shares based on market price

Common Shares Debt Settlement BioNxt Solutions Inc. Settlement Agreement Creditor
PRESS RELEASE

published on 01/30/2024 at 05:48, 9 months 22 days ago

BIONXT SOLUTIONS ANNOUNCES CLOSING OF FINAL TRANCHE OF NON-BROKERED PRIVATE PLACEMENT
BioNxt Solutions Inc. closes final tranche of non-brokered private placement, raising gross proceeds of $288,000 to fund drug development and working capital purposes

Private Placement Working Capital Investment Drug Development BioNxt Solutions Inc.
PRESS RELEASE

published on 12/22/2023 at 09:05, 10 months 30 days ago

BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financing
PRESS RELEASE

published on 12/22/2023 at 01:50, 10 months 30 days ago

BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financing
PRESS RELEASE

published on 12/12/2023 at 09:05, 11 months 9 days ago

BioNxt Receives Delivery of Premium Commercial Coating and Cutting Equipment for Commercial Manufacturing of Drug Delivery Products
PRESS RELEASE

published on 12/09/2023 at 04:30, 11 months 12 days ago

BioNxt Solutions Announces Completion of Debenture and Interest Settlement and Issuance of Finder’s Warrants
PRESS RELEASE

published on 11/25/2023 at 01:44, 11 months 26 days ago

Bionxt Solutions Announces Convertible Debenture and Interest Settlement

Accesswire

Published on 11/21/2024 at 19:25, 13 minutes ago

Ibero Mining Reports Results From Deep Undercut Drill Hole At Miguel Vacas Mine
Published on 11/21/2024 at 17:35, 2 hours 3 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 2 hours 8 minutes ago

SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 3 hours 8 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 3 hours 37 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 36 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 1 hour 1 minute ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 1 hour 39 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 1 hour 46 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 1 hour 46 minutes ago

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.

Les Echos

Published on 11/21/2024 at 06:58, 12 hours 40 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 12 hours 40 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 12 hours 40 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 23 hours 30 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE